论文信息 - First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial - 字舞流文

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

R. Greil | J. Gribben | I. Flinn | K. Kwei | A. Tedeschi | J. Dean | M. Šimkovič | D. Gill | L. Larratt | B. Anz | F. Demirkan | J. Novák | V. Strugov | C. Moreno | E. Hsu | S. Dai | Kevin Kwei